Flow Cytometry Market Drivers, by Top Companies 2023-29
The global flow cytometry market size was valued at USD 4.7 billion in 2022 and is poised to grow at a of CAGR of 8.4% during the forecast period 2023 to 2029. The increasing incidence and prevalence of HIV/AIDS and cancer worldwide, the growing use of flow cytometry techniques in academic and research settings, the expansion of public-private initiatives in the fields of immunology and immuno-oncology research, technological advancements, the increasing integration of AI platforms into flow cytometry workflows, and improvements in flow cytometry software all contribute to the market's growth. Flow cytometry has become a crucial technique for safety and exploratory objectives during drug research and development procedures. From target identification and screening to pre-clinical studies, this technology is utilized. In a little amount of time, flow cytometry can analyze a vast number of particles and deliver statistically reliable data regarding cell populations. These capabilities, along with its multi-parametric methodology, make flow cytometry an ideal tool for drug discovery and development in the pharmaceutical and biopharmaceutical sectors.
view detailed report description here: https://precisionbusinessinsights.com/market-reports/flow-cytometry-market/
The global flow cytometry market segmentation: 1) By Product: Instruments (Cell Analyzers and Cell Sorters), Reagents & Consumables, Software, Accessories, and Services. 2) By Technology: Cell-based and Bead-based 3) By Application: Research, Apoptosis, Cell Sorting, Cell Cycle Analysis, Immunology, Cell Viability, Industrial, Clinical 4) By End-use: Commercial Organizations, Hospitals, Academic Institutes, and Clinical Testing Labs Cell-based Flow Cytometry Segment to Dominate the Flow Cytometry Market The cell-based flow cytometry segment is expected to account for a larger revenue share in the global flow cytometry market, with a value share worldwide. It is projected to grow at 8.6% CAGR between 2022 and 2028. Due to the ability to assess compound activity against molecular targets while surrounded by living cells, cell-based flow cytometry is employed more frequently in drug discovery. The market for cell-based flow cytometry is expanding due to the accessibility of automated technologies like high-throughput flow cytometry for cell-based screening.
Asia Pacific Flow Cytometry Market The Asia Pacific market is expected to increase in the global flow cytometry market over the forecast period. It is projected to grow at a CAGR of 9.1% in the coming years. The significant expansion of the pharmaceutical and biotechnology sectors in developing nations like China and India is responsible for this tremendous growth. The lucrative increase in this region has also benefited from ongoing government assistance with developing the pharmaceutical sector in developing nations. The market for flow cytometry products in the region is also predicted to increase dramatically due to ongoing R&D efforts in the fields of cancer and infectious illnesses, such as COVID-19. Additionally, throughout the forecast period, market expansion in the region is anticipated to be supported by significant research efforts by regional players to advance or develop cutting-edge flow cytometry solutions.
Request sample report at https://precisionbusinessinsights.com/request-sample?product_id=19041
Key players’ profiles in the flow cytometry market report are Danaher Corporation, Becton, Dickinson and Company, Luminex Corporation, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Miltenyi Biotec, Sysmex Corporation, Stratedigm, Inc., Apogee Flow Systems Ltd., Sony Biotechnology, Inc., and Thermo Fisher Scientific, Inc.
About Precision Business Insights: We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.
Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.
Contact: Mr. Satya Precision Business Insights | Toll Free: +1 866 598 1553 Email: sales@precisionbusinessinsights.com Kemp House, 152 – 160 City Road, London EC1V 2NX Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747